Programme Day 1

08.00 - 10.00

GFHT workshops
Hall: Auditorium

COMETH meeting
Hall: Callelongue

Master class INNOVTE
Hall: Endoume 1

10.00 - 10.30

Coffee break

10.30 - 12.15

GFHT workshops
Hall: Auditorium

COMETH meeting
Hall: Callelongue

Master class INNOVTE
Hall: Endoume 1

12.15 - 13.15

Lunch break

13.15 - 15.00

Compendium in bleeding disorders (endorsed by COMETH-GFHT)
Hall: Auditorium

 

 

13.15 – 13.40: Gastrointestinal bleeding in Willebrand disease by Sophie Susen, Lille

13.40 – 14.05: Constitutional defects in Fibrinogen by Aurélien Lebreton, Clermont Ferrand

14.05 – 14.30: Thrombosis prevention in hemophiliacs undergoing surgery: where are we today? By Yessim Dargaud, Lyon

14.30 – 14.55: Understanding acquired Factor X deficiencies by Olivier Christophe Paris

 

Fibrinolysis : New therapeutic aspects (endorsed by GFHT-GIHP- INNOVTE-SFMV)
Hall: Callelongue

 

13.15 – 13.45: Impact of t-PA on brain function by Denis Vivien, Caen

13.45 – 14.15: Antifibrinolytics and perioperative management by Paul Zufferey, Saint-Etienne

14.15 – 14.45: New strategies for improving fibrinolysis in VTE by Gilles Pernod, Grenoble

14.45 – 15.00: Q&A

Bleeding and platelet disorders (endorsed by the Club des megacaryocytes and GFHT)
Hall: Endoume 1

 

13.15 – 13.45: Ticagrelor reversal by Anne Godier, Paris

13.45 – 14.15: CalDAG-GEFI the ignition sparkle of platelet activation by Mattias Canault, Marseille

14.15 – 14.45: Bleeding and inflammation by Benoit Ho-Thin-Noé

14.45 – 15.00: Q&A

15.00 - 15.15

Short break

15.15 - 16.15

Plenary lecture – Fake news, fake science – Frits Rosendaal, The Netherlands
Hall: Auditorium

16.15 - 17.15

Science, fast and furious
Hall: Auditorium

16.15 – 16.30: Frequency and clinical impact of anti-PF4/Heparin antibodies in patients treated with Extra-Corporeal Membrane Oxygenation by Caroline Vayne, France

16.30 – 16.45: Eltrombopag (EPAG) improved platelet counts with similar safety in patients with persistent or chronic immune thrombocytopenia (ITP): Subgroup analyses of a 2-year, Phase IV, open-label study by Raymond Wong, Hongkong

16.45 – 17.00: Targeting Protease Nexin-1, a natural anticoagulant, to control bleeding in hemophilia A by Karen Aymonnier, France

17.00 – 17.15: Slc44a2 deficient mice exhibit less severity of thrombosis in a stenosis model of DVT by Chrissta Maracle, The Netherlands

17.15 - 17.45

Coffee break & poster viewing

17.45 - 18.30

Opening ceremony
Hall: Auditorium

All delegates are invited to kick off their ECTH 2018 experience at the vibrant Opening Ceremony in the Auditorium. You will be welcomed by Yves Gruel (Host ECTH 2018 and President GFHT) and Frits Rosendaal (Board ECTH 2018).

18.30 - 19.30

Welcome reception

After an entertaining Opening Ceremony, meet your peers and network with fellow congress delegates, enjoy a drink and some delicious bites. Welcome to Marseille!